Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 8. Click on ID to see further detail.
IDOV_4971 | Virus nameVaccinia virus | Virus strainwild type | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration2 MOI | In-vitro result60% cell viability after 24 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4972 | Virus nameVaccinia virus | Virus strainwild type | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result40% cell viability after 24 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4973 | Virus nameVaccinia virus | Virus strainwild type | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration2 MOI | In-vitro result20% cell viability after 48 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4974 | Virus nameVaccinia virus | Virus strainwild type | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result5% cell viability after 48 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4975 | Virus nameVaccinia virus | Virus strainvv-IL-24 | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationInsertion of IL-24 gene in tk locus | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing IL-24 gene | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration2 MOI | In-vitro result44% cell viability after 24 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4976 | Virus nameVaccinia virus | Virus strainvv-IL-24 | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationInsertion of IL-24 gene in tk locus | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing IL-24 gene | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result35% cell viability after 24 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4977 | Virus nameVaccinia virus | Virus strainvv-IL-24 | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationInsertion of IL-24 gene in tk locus | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing IL-24 gene | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration2 MOI | In-vitro result20% cell viability after 48 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |
IDOV_4978 | Virus nameVaccinia virus | Virus strainvv-IL-24 | Virus genome typeDNA | Virus familyPoxviridae | Virus genome modificationInsertion of IL-24 gene in tk locus | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing IL-24 gene | Source of cell lineShanghai cell collection | Origin of cell lineLewis lung cancer cell line | Cell lineLLC | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result2% cell viability after 48 hours | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedInduction of apoptosis | Immunogenic effectNA | Clinical trialNA | PMID27208781 |